Former IBD 50 Stock Revance Implodes As Its ' Prestige ' Plan Goes Up In Smoke

Revance is reversing course to stay competitive with AbbVie's aesthetics drug, Botox — and RVNC stock crashed Tuesday in response. The post Former IBD 50 Stock Revance Implodes As Its 'Prestige' Plan Goes Up In Smoke appeared first on Investor's Business Daily.#abbvie #botox #smoke

Source: Reuters: Health - September 19, 2023 Category: Consumer Health News Source Type: news